Oncology BD Executive - Global Licensing (Remote)

Proclinical; United States; Remote; USD 240,000 - 390,000; Full time

Job summary

Proclinical seeks an experienced oncology business development leader to drive global licensing-out transactions and strategic partnerships for the oncology pipeline. The director will lead end-to-end deals from identification through term sheets to definitive agreements, collaborating with the CBO, executive management, and cross-functional teams to maximize asset value.

The role demands deep oncology drug development knowledge, outstanding negotiation and senior-stakeholder skills, and a

Qualifications

• Advanced degree in life sciences, medicine, pharmacy, oncology, biotechnology, or related field. PhD preferred; MBA is an advantage.
• Proven years of relevant experience in biopharmaceutical business development, licensing, corporate development, or strategic partnering, with seniority appropriate to Director - Executive Director level.
• Strong understanding of oncology drug development, clinical trial design, competitive landscapes, and the commercial considerations relevant to oncology assets. Demonstrated experience leading or contributing to oncology licensing-out transactions, including term sheet negotiation, due diligence, and definitive agreement execution.
• Established relationships with pharmaceutical and biotechnology companies active in oncology development and commercialization.
• Strong knowledge of licensing economics, transaction structuring, intellectual property, milestones, and global commercialization rights.
• Proven ability to lead complex cross-border negotiations and coordinate multidisciplinary transaction teams.
• Excellent strategic thinking, negotiation, communication, and stakeholder management skills.
• Fluency in English is required; Mandarin Chinese proficiency is preferred.

Responsibilities

• Lead end-to-end global licensing-out transactions for oncology assets, from partner identification and initial engagement through due diligence, term sheet negotiation, definitive agreements, and deal closing.
• Drive ongoing licensing discussions and advance transactions from the Term Sheet stage toward definitive licensing agreements.
• Develop asset-specific licensing strategies based on clinical data, mechanism of action, competitive positioning, target patient populations, and market opportunities.
• Lead negotiations on upfront payments, development and regulatory milestones, royalties, territorial rights, exclusivity, intellectual property, and development and commercialization responsibilities.
• Develop transaction structures that optimize asset value while addressing commercial, clinical, regulatory, and execution risks.
• Develop and execute global licensing-out strategies for oncology pipeline assets.

Skills

Oncology BD

Transaction execution

Commercial acumen

Negotiation

Stakeholder management

Cross-functional leadership

English proficiency

Mandarin preferred

Education

PhD preferred

MBA advantageous

Job description

Proclinical seeks an experienced oncology business development leader to drive global licensing-out transactions and strategic partnerships for the oncology pipeline. The director will lead end-to-end deals from identification through term sheets to definitive agreements, collaborating with the CBO, executive management, and cross-functional teams to maximize asset value.

The role demands deep oncology drug development knowledge, outstanding negotiation and senior-stakeholder skills, and a